Zyversa Therapeutics Stock Price History

ZVSA Stock   0.75  0.05  7.14%   
If you're considering investing in ZyVersa Stock, it is important to understand the factors that can impact its price. As of today, the current price of ZyVersa Therapeutics stands at 0.75, as last reported on the 21st of March, with the highest price reaching 0.75 and the lowest price hitting 0.70 during the day. ZyVersa Therapeutics shows Sharpe Ratio of -0.0865, which attests that the company had a -0.0865 % return per unit of risk over the last 3 months. ZyVersa Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out ZyVersa Therapeutics' Market Risk Adjusted Performance of (1.23), mean deviation of 4.57, and Standard Deviation of 6.41 to validate the risk estimate we provide.
  
At present, ZyVersa Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 39.2 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 59.6 K. . At present, ZyVersa Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.07, whereas Price Earnings Ratio is forecasted to decline to (0.01). ZyVersa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0865

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsZVSA

Estimated Market Risk

 6.33
  actual daily
56
56% of assets are less volatile

Expected Return

 -0.55
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average ZyVersa Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ZyVersa Therapeutics by adding ZyVersa Therapeutics to a well-diversified portfolio.
Price Book
0.2711
Book Value
6.542
Enterprise Value
-1.2 M
Enterprise Value Ebitda
(2.21)
Shares Float
2.3 M

ZyVersa Therapeutics Stock Price History Chart

There are several ways to analyze ZyVersa Stock price data. The simplest method is using a basic ZyVersa candlestick price chart, which shows ZyVersa Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 23, 20251.51
Lowest PriceMarch 20, 20250.7

ZyVersa Therapeutics March 21, 2025 Stock Price Synopsis

Various analyses of ZyVersa Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ZyVersa Stock. It can be used to describe the percentage change in the price of ZyVersa Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ZyVersa Stock.
ZyVersa Therapeutics Price Daily Balance Of Power 1.00 
ZyVersa Therapeutics Price Action Indicator 0.05 
ZyVersa Therapeutics Accumulation Distribution 2,499 
ZyVersa Therapeutics Price Rate Of Daily Change 1.07 

ZyVersa Therapeutics March 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in ZyVersa Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use ZyVersa Therapeutics intraday prices and daily technical indicators to check the level of noise trading in ZyVersa Stock and then apply it to test your longer-term investment strategies against ZyVersa.

ZyVersa Stock Price History Data

The price series of ZyVersa Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.81 with a coefficient of variation of 17.21. The daily prices for the period are distributed with arithmetic mean of 1.17. The median price for the last 90 days is 1.22. The company experienced 1:10 stock split on 26th of April 2024.
OpenHighLowCloseVolume
03/21/2025 0.70  0.75  0.70  0.75  37,485 
03/20/2025 0.76  0.76  0.70  0.70  37,625 
03/19/2025 0.73  0.76  0.70  0.76  43,249 
03/18/2025 0.76  0.79  0.72  0.74  108,447 
03/17/2025 0.79  0.80  0.75  0.79  49,226 
03/14/2025 0.78  0.82  0.76  0.79  68,571 
03/13/2025 0.82  0.84  0.80  0.80  64,137 
03/12/2025 0.95  0.96  0.80  0.82  1,135,902 
03/11/2025 0.93  0.98  0.90  0.95  32,141 
03/10/2025 0.96  1.00  0.92  0.94  20,543 
03/07/2025 0.89  1.06  0.86  0.98  168,352 
03/06/2025 0.94  0.95  0.85  0.89  214,544 
03/05/2025 1.02  1.13  0.94  0.94  6,013,808 
03/04/2025 1.06  1.08  1.01  1.08  58,642 
03/03/2025 1.11  1.12  1.05  1.05  22,242 
02/28/2025 1.15  1.17  1.11  1.13  31,865 
02/27/2025 1.18  1.19  1.15  1.17  38,589 
02/26/2025 1.11  1.18  1.09  1.18  33,514 
02/25/2025 1.13  1.16  1.06  1.12  49,376 
02/24/2025 1.18  1.20  1.11  1.12  69,784 
02/21/2025 1.25  1.26  1.17  1.22  71,172 
02/20/2025 1.23  1.25  1.20  1.22  25,396 
02/19/2025 1.13  1.29  1.12  1.22  201,527 
02/18/2025 1.20  1.24  1.19  1.19  38,499 
02/14/2025 1.30  1.32  1.23  1.24  84,935 
02/13/2025 1.28  1.32  1.26  1.30  37,859 
02/12/2025 1.26  1.37  1.20  1.31  117,411 
02/11/2025 1.24  1.27  1.22  1.26  81,150 
02/10/2025 1.24  1.31  1.20  1.22  130,713 
02/07/2025 1.25  1.26  1.22  1.23  46,919 
02/06/2025 1.30  1.32  1.20  1.24  92,659 
02/05/2025 1.29  1.39  1.25  1.28  97,022 
02/04/2025 1.30  1.31  1.24  1.28  62,387 
02/03/2025 1.32  1.37  1.30  1.36  67,475 
01/31/2025 1.39  1.39  1.34  1.39  32,364 
01/30/2025 1.35  1.39  1.34  1.38  17,118 
01/29/2025 1.34  1.42  1.34  1.37  17,163 
01/28/2025 1.40  1.43  1.35  1.36  40,445 
01/27/2025 1.44  1.44  1.37  1.41  73,487 
01/24/2025 1.52  1.52  1.43  1.48  58,658 
01/23/2025 1.39  1.54  1.33  1.51  212,275 
01/22/2025 1.49  1.49  1.35  1.40  121,868 
01/21/2025 1.42  1.54  1.42  1.48  205,976 
01/17/2025 1.34  1.43  1.33  1.42  130,972 
01/16/2025 1.36  1.47  1.31  1.35  133,368 
01/15/2025 1.49  1.54  1.32  1.41  286,242 
01/14/2025 1.31  1.60  1.31  1.49  724,130 
01/13/2025 1.43  1.63  1.25  1.33  1,264,769 
01/10/2025 1.65  1.95  1.35  1.47  38,305,078 
01/08/2025 1.18  1.21  1.18  1.18  75,462 
01/07/2025 1.24  1.27  1.20  1.23  43,030 
01/06/2025 1.25  1.28  1.19  1.25  77,567 
01/03/2025 1.10  1.27  1.09  1.24  168,521 
01/02/2025 1.06  1.12  1.05  1.09  58,775 
12/31/2024 1.05  1.10  1.04  1.06  52,816 
12/30/2024 1.11  1.13  1.06  1.07  147,680 
12/27/2024 1.25  1.29  1.00  1.15  169,196 
12/26/2024 1.12  1.23  1.10  1.23  63,357 
12/24/2024 1.17  1.17  1.10  1.15  43,096 
12/23/2024 1.13  1.23  1.12  1.17  81,351 
12/20/2024 1.19  1.33  1.08  1.14  281,187 

About ZyVersa Therapeutics Stock history

ZyVersa Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ZyVersa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ZyVersa Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ZyVersa Therapeutics stock prices may prove useful in developing a viable investing in ZyVersa Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding112.1 K59.6 K
Net Loss-12.7 M-13.3 M

ZyVersa Therapeutics Stock Technical Analysis

ZyVersa Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ZyVersa Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ZyVersa Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Share Portfolio Now

   

Share Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

ZyVersa Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for ZyVersa Therapeutics' price direction in advance. Along with the technical and fundamental analysis of ZyVersa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ZyVersa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for ZyVersa Stock analysis

When running ZyVersa Therapeutics' price analysis, check to measure ZyVersa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZyVersa Therapeutics is operating at the current time. Most of ZyVersa Therapeutics' value examination focuses on studying past and present price action to predict the probability of ZyVersa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZyVersa Therapeutics' price. Additionally, you may evaluate how the addition of ZyVersa Therapeutics to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stocks Directory
Find actively traded stocks across global markets